

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 9.54564026 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55028762 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.55028762 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.20738842 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.20738842 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.72426354 |
| 7 | oxidative demethylation (GO:0070989) | 6.36536027 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.28104799 |
| 9 | * drug metabolic process (GO:0017144) | 6.23511175 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.97983557 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.97983557 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.97983557 |
| 13 | ethanol metabolic process (GO:0006067) | 5.95055128 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.84298023 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.80646408 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.71371756 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.70311238 |
| 18 | protein activation cascade (GO:0072376) | 5.65333650 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.64856004 |
| 20 | opsonization (GO:0008228) | 5.56938155 |
| 21 | urea metabolic process (GO:0019627) | 5.48661208 |
| 22 | urea cycle (GO:0000050) | 5.48661208 |
| 23 | phenylpropanoid metabolic process (GO:0009698) | 5.46134951 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.43491743 |
| 25 | cysteine metabolic process (GO:0006534) | 5.38023125 |
| 26 | complement activation, classical pathway (GO:0006958) | 5.37958019 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 5.35802222 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.33601587 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.19448055 |
| 30 | protein carboxylation (GO:0018214) | 5.19448055 |
| 31 | complement activation, alternative pathway (GO:0006957) | 5.15305636 |
| 32 | regulation of fibrinolysis (GO:0051917) | 5.13616545 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.13439361 |
| 34 | acute-phase response (GO:0006953) | 5.09738027 |
| 35 | regulation of plasminogen activation (GO:0010755) | 5.08772280 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 5.05389714 |
| 37 | negative regulation of protein activation cascade (GO:2000258) | 5.05189284 |
| 38 | regulation of humoral immune response (GO:0002920) | 5.03398573 |
| 39 | bile acid metabolic process (GO:0008206) | 5.03094477 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.99057426 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96540973 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.88413598 |
| 43 | S-adenosylmethionine metabolic process (GO:0046500) | 4.85858327 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.80637387 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.77082936 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.76817442 |
| 47 | lysine catabolic process (GO:0006554) | 4.74706957 |
| 48 | lysine metabolic process (GO:0006553) | 4.74706957 |
| 49 | cytolysis (GO:0019835) | 4.72680173 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.72563954 |
| 51 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.72317667 |
| 52 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.72317667 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 4.72190545 |
| 54 | reverse cholesterol transport (GO:0043691) | 4.72061751 |
| 55 | regulation of complement activation (GO:0030449) | 4.65963098 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.64877548 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 4.64801132 |
| 58 | macromolecular complex remodeling (GO:0034367) | 4.64801132 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 4.64801132 |
| 60 | negative regulation of hemostasis (GO:1900047) | 4.60353647 |
| 61 | negative regulation of blood coagulation (GO:0030195) | 4.60353647 |
| 62 | triglyceride homeostasis (GO:0070328) | 4.58789582 |
| 63 | acylglycerol homeostasis (GO:0055090) | 4.58789582 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.56649249 |
| 65 | negative regulation of sterol transport (GO:0032372) | 4.55383163 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 4.55383163 |
| 67 | phospholipid efflux (GO:0033700) | 4.41500743 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 4.40689081 |
| 69 | alkaloid metabolic process (GO:0009820) | 4.34182427 |
| 70 | glycine metabolic process (GO:0006544) | 4.30924379 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.29765838 |
| 72 | bile acid and bile salt transport (GO:0015721) | 4.27472489 |
| 73 | cellular glucuronidation (GO:0052695) | 4.27209992 |
| 74 | drug catabolic process (GO:0042737) | 4.26129425 |
| 75 | indolalkylamine metabolic process (GO:0006586) | 4.24455637 |
| 76 | coenzyme catabolic process (GO:0009109) | 4.24370613 |
| 77 | negative regulation of complement activation (GO:0045916) | 4.23426167 |
| 78 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.21604002 |
| 79 | negative regulation of wound healing (GO:0061045) | 4.21353453 |
| 80 | glutamate metabolic process (GO:0006536) | 4.17401060 |
| 81 | negative regulation of coagulation (GO:0050819) | 4.17288621 |
| 82 | serine family amino acid metabolic process (GO:0009069) | 4.15825190 |
| 83 | imidazole-containing compound metabolic process (GO:0052803) | 4.14443305 |
| 84 | amine catabolic process (GO:0009310) | 4.13838014 |
| 85 | cellular biogenic amine catabolic process (GO:0042402) | 4.13838014 |
| 86 | cholesterol efflux (GO:0033344) | 4.08929313 |
| 87 | ethanol oxidation (GO:0006069) | 4.07333461 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 4.07298064 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 4.04272927 |
| 90 | hormone catabolic process (GO:0042447) | 4.00518944 |
| 91 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96136364 |
| 92 | ketone body metabolic process (GO:1902224) | 3.95117945 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.95091980 |
| 94 | aldehyde catabolic process (GO:0046185) | 3.92598573 |
| 95 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.91465265 |
| 96 | arginine metabolic process (GO:0006525) | 3.91026953 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.88403213 |
| 98 | positive regulation of blood coagulation (GO:0030194) | 3.85996015 |
| 99 | positive regulation of hemostasis (GO:1900048) | 3.85996015 |
| 100 | plasma lipoprotein particle assembly (GO:0034377) | 3.85442727 |
| 101 | fibrinolysis (GO:0042730) | 3.82591930 |
| 102 | organic acid catabolic process (GO:0016054) | 3.81786775 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.81786775 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.81228058 |
| 105 | uronic acid metabolic process (GO:0006063) | 3.81228058 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.80864557 |
| 107 | acute inflammatory response (GO:0002526) | 3.80038981 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79933528 |
| 109 | exogenous drug catabolic process (GO:0042738) | 3.77337723 |
| 110 | acetyl-CoA metabolic process (GO:0006084) | 3.74750843 |
| 111 | negative regulation of lipase activity (GO:0060192) | 3.74524590 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.71949981 |
| 113 | flavonoid metabolic process (GO:0009812) | 3.69281817 |
| 114 | phospholipid homeostasis (GO:0055091) | 3.68514212 |
| 115 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.66540378 |
| 116 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.66540378 |
| 117 | cofactor catabolic process (GO:0051187) | 3.66355246 |
| 118 | sterol homeostasis (GO:0055092) | 3.66349619 |
| 119 | regulation of cholesterol homeostasis (GO:2000188) | 3.64838440 |
| 120 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.62864636 |
| 121 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61733046 |
| 122 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59925022 |
| 123 | regulation of acute inflammatory response (GO:0002673) | 3.59308886 |
| 124 | drug transmembrane transport (GO:0006855) | 3.59137689 |
| 125 | monocarboxylic acid catabolic process (GO:0072329) | 3.58602286 |
| 126 | complement activation (GO:0006956) | 3.57982236 |
| 127 | epoxygenase P450 pathway (GO:0019373) | 3.56330426 |
| 128 | fatty acid oxidation (GO:0019395) | 3.56311942 |
| 129 | steroid catabolic process (GO:0006706) | 3.55637171 |
| 130 | positive regulation of coagulation (GO:0050820) | 3.54710749 |
| 131 | * xenobiotic metabolic process (GO:0006805) | 3.48366047 |
| 132 | response to mercury ion (GO:0046689) | 3.44688809 |
| 133 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.38056151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.36226706 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13987171 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.73731066 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48965673 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.47607291 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.23299469 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.95618356 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.96937572 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.88705293 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24652618 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10309054 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7255098 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97094977 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74819075 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60725561 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50009945 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40110952 |
| 18 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36770749 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25885383 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23766756 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18991604 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18121047 |
| 23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16562305 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16418753 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05699299 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02621159 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01252741 |
| 28 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.01203669 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00386040 |
| 30 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.94622763 |
| 31 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94556256 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93648125 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92144421 |
| 34 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91750933 |
| 35 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.91151379 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89683226 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89228664 |
| 38 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88945648 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88361967 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85070288 |
| 41 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84478108 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84201826 |
| 43 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.83131882 |
| 44 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82719615 |
| 45 | NFYA_21822215_ChIP-Seq_K562_Human | 0.80279082 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79614331 |
| 47 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77937325 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77443714 |
| 49 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76399432 |
| 50 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76047251 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76014752 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.75313250 |
| 53 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.72394149 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71920289 |
| 55 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71369161 |
| 56 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69972937 |
| 57 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.69967513 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69770336 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69588437 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69351675 |
| 61 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69029049 |
| 62 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.68387826 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.67503700 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67313759 |
| 65 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.67214624 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.67088556 |
| 67 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.66113748 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.65959302 |
| 69 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.65810419 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64767092 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64767092 |
| 72 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.64000783 |
| 73 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.63126249 |
| 74 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62998047 |
| 75 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62849556 |
| 76 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62505521 |
| 77 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61485925 |
| 78 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60670638 |
| 79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60219035 |
| 80 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.59259523 |
| 81 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.59258024 |
| 82 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.58956643 |
| 83 | NFYB_21822215_ChIP-Seq_K562_Human | 0.57963277 |
| 84 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.57906033 |
| 85 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.57817228 |
| 86 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.57709598 |
| 87 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.57697179 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57388775 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.57049824 |
| 90 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.57035709 |
| 91 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.55764802 |
| 92 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.55540318 |
| 93 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.54606372 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.54406300 |
| 95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.53651066 |
| 96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.53616181 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53169107 |
| 98 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.53018936 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52490920 |
| 100 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.52334462 |
| 101 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52267105 |
| 102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52204741 |
| 103 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52069676 |
| 104 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.51870756 |
| 105 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51690344 |
| 106 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.51196513 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51012879 |
| 108 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.50971282 |
| 109 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.50585983 |
| 110 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50337936 |
| 111 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50298650 |
| 112 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.50209607 |
| 113 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50204583 |
| 114 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50038040 |
| 115 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49280522 |
| 116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.49192326 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.47980431 |
| 118 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47287442 |
| 119 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.46792470 |
| 120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.46749917 |
| 121 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45931665 |
| 122 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45490511 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45470613 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44567857 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42501544 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42457242 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42194653 |
| 128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41798374 |
| 129 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41428773 |
| 130 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41262511 |
| 131 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40420852 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39747291 |
| 133 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39130887 |
| 134 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.38922530 |
| 135 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38686103 |
| 136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38479220 |
| 137 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37540182 |
| 138 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36683280 |
| 139 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36618294 |
| 140 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36231448 |
| 141 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35983652 |
| 142 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.35973160 |
| 143 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35438463 |
| 144 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.35377139 |
| 145 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35261064 |
| 146 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.35174912 |
| 147 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.34941418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.37097753 |
| 2 | MP0005360_urolithiasis | 7.52757961 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.33616383 |
| 4 | MP0005365_abnormal_bile_salt | 6.10803882 |
| 5 | * MP0008875_abnormal_xenobiotic_pharmacok | 5.02452138 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.05161662 |
| 7 | MP0003252_abnormal_bile_duct | 3.85814927 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.63082353 |
| 9 | MP0009840_abnormal_foam_cell | 3.18892995 |
| 10 | MP0005083_abnormal_biliary_tract | 2.99765019 |
| 11 | MP0005332_abnormal_amino_acid | 2.87565758 |
| 12 | MP0003195_calcinosis | 2.84609752 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.52648786 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.30059321 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.27614867 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.16880066 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.14703350 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.97350529 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.86572046 |
| 20 | MP0003868_abnormal_feces_composition | 1.80116466 |
| 21 | MP0001764_abnormal_homeostasis | 1.69482278 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61568527 |
| 23 | MP0005451_abnormal_body_composition | 1.56243270 |
| 24 | MP0009697_abnormal_copulation | 1.45809883 |
| 25 | MP0003186_abnormal_redox_activity | 1.36812882 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.35431768 |
| 27 | MP0003011_delayed_dark_adaptation | 1.28230549 |
| 28 | MP0002132_abnormal_respiratory_system | 1.26371478 |
| 29 | MP0005670_abnormal_white_adipose | 1.26122007 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.21535396 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.17828175 |
| 32 | * MP0000598_abnormal_liver_morphology | 1.14961204 |
| 33 | MP0005647_abnormal_sex_gland | 1.12279955 |
| 34 | MP0000604_amyloidosis | 1.05041203 |
| 35 | MP0002254_reproductive_system_inflammat | 0.99470176 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 0.97009843 |
| 37 | MP0002876_abnormal_thyroid_physiology | 0.97003037 |
| 38 | * MP0009763_increased_sensitivity_to | 0.96761999 |
| 39 | MP0005187_abnormal_penis_morphology | 0.93862034 |
| 40 | MP0004130_abnormal_muscle_cell | 0.93394968 |
| 41 | MP0002282_abnormal_trachea_morphology | 0.91518292 |
| 42 | MP0008469_abnormal_protein_level | 0.87544553 |
| 43 | * MP0009764_decreased_sensitivity_to | 0.87394413 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 0.87306884 |
| 45 | * MP0009642_abnormal_blood_homeostasis | 0.87123491 |
| 46 | MP0002971_abnormal_brown_adipose | 0.86386993 |
| 47 | MP0010368_abnormal_lymphatic_system | 0.86195075 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.83527692 |
| 49 | MP0001915_intracranial_hemorrhage | 0.83434333 |
| 50 | MP0001661_extended_life_span | 0.81685646 |
| 51 | MP0005408_hypopigmentation | 0.80262890 |
| 52 | MP0005334_abnormal_fat_pad | 0.80259181 |
| 53 | MP0005376_homeostasis/metabolism_phenot | 0.78775710 |
| 54 | MP0005535_abnormal_body_temperature | 0.77476848 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 0.77173857 |
| 56 | MP0003690_abnormal_glial_cell | 0.74399456 |
| 57 | MP0003879_abnormal_hair_cell | 0.72774925 |
| 58 | MP0001756_abnormal_urination | 0.72156504 |
| 59 | MP0002249_abnormal_larynx_morphology | 0.71818850 |
| 60 | MP0005666_abnormal_adipose_tissue | 0.68233878 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 0.66442294 |
| 62 | * MP0009765_abnormal_xenobiotic_induced | 0.65087373 |
| 63 | MP0003329_amyloid_beta_deposits | 0.64258425 |
| 64 | MP0005266_abnormal_metabolism | 0.63621177 |
| 65 | MP0009785_altered_susceptibility_to | 0.62292634 |
| 66 | MP0005448_abnormal_energy_balance | 0.61349887 |
| 67 | MP0009053_abnormal_anal_canal | 0.60352084 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 0.57694789 |
| 69 | MP0000639_abnormal_adrenal_gland | 0.57275198 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.55325290 |
| 71 | MP0006035_abnormal_mitochondrial_morpho | 0.54326858 |
| 72 | MP0005464_abnormal_platelet_physiology | 0.50119158 |
| 73 | MP0003638_abnormal_response/metabolism_ | 0.49854600 |
| 74 | MP0005395_other_phenotype | 0.48468295 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.48154050 |
| 76 | MP0003724_increased_susceptibility_to | 0.47329867 |
| 77 | MP0009115_abnormal_fat_cell | 0.46805168 |
| 78 | MP0005023_abnormal_wound_healing | 0.46263251 |
| 79 | MP0002928_abnormal_bile_duct | 0.46086437 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.45667400 |
| 81 | MP0002822_catalepsy | 0.45473738 |
| 82 | MP0003953_abnormal_hormone_level | 0.45331478 |
| 83 | MP0008873_increased_physiological_sensi | 0.43854476 |
| 84 | MP0009672_abnormal_birth_weight | 0.41468381 |
| 85 | MP0003075_altered_response_to | 0.40813352 |
| 86 | MP0003436_decreased_susceptibility_to | 0.40454540 |
| 87 | MP0002970_abnormal_white_adipose | 0.39991335 |
| 88 | * MP0008874_decreased_physiological_sensi | 0.39219855 |
| 89 | MP0005248_abnormal_Harderian_gland | 0.38821915 |
| 90 | MP0003718_maternal_effect | 0.38748363 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.38639221 |
| 92 | MP0000467_abnormal_esophagus_morphology | 0.38139018 |
| 93 | MP0002168_other_aberrant_phenotype | 0.37876186 |
| 94 | * MP0008872_abnormal_physiological_respon | 0.34945482 |
| 95 | MP0002796_impaired_skin_barrier | 0.34572508 |
| 96 | MP0000249_abnormal_blood_vessel | 0.34167307 |
| 97 | MP0001853_heart_inflammation | 0.33975192 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.32740046 |
| 99 | MP0005166_decreased_susceptibility_to | 0.32606649 |
| 100 | MP0001881_abnormal_mammary_gland | 0.31546902 |
| 101 | MP0001243_abnormal_dermal_layer | 0.31144592 |
| 102 | MP0004883_abnormal_blood_vessel | 0.29922056 |
| 103 | MP0004043_abnormal_pH_regulation | 0.29274120 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 0.28384897 |
| 105 | MP0006082_CNS_inflammation | 0.27850292 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.26855826 |
| 107 | MP0005397_hematopoietic_system_phenotyp | 0.26309967 |
| 108 | MP0001545_abnormal_hematopoietic_system | 0.26309967 |
| 109 | MP0003959_abnormal_lean_body | 0.26017456 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.25839914 |
| 111 | MP0002060_abnormal_skin_morphology | 0.25767244 |
| 112 | MP0005164_abnormal_response_to | 0.25553274 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.25331138 |
| 114 | MP0001986_abnormal_taste_sensitivity | 0.24752384 |
| 115 | MP0002090_abnormal_vision | 0.24646586 |
| 116 | MP0000566_synostosis | 0.21515571 |
| 117 | MP0001851_eye_inflammation | 0.20949939 |
| 118 | MP0003633_abnormal_nervous_system | 0.19751303 |
| 119 | MP0010386_abnormal_urinary_bladder | 0.18694890 |
| 120 | MP0002128_abnormal_blood_circulation | 0.18503103 |
| 121 | MP0001440_abnormal_grooming_behavior | 0.18439453 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.18259812 |
| 123 | MP0005197_abnormal_uvea_morphology | 0.17329904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.34334918 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.19685413 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.02704489 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.46587279 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.25721206 |
| 6 | Xanthomatosis (HP:0000991) | 6.24134636 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.17272410 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.58135681 |
| 9 | Complement deficiency (HP:0004431) | 5.08634385 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.69538594 |
| 11 | Hyperammonemia (HP:0001987) | 4.68929822 |
| 12 | Joint hemorrhage (HP:0005261) | 4.61726862 |
| 13 | Hyperglycinemia (HP:0002154) | 4.51751584 |
| 14 | Epidermoid cyst (HP:0200040) | 4.50239261 |
| 15 | Ketosis (HP:0001946) | 4.44163846 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.33235673 |
| 17 | Hyperglycinuria (HP:0003108) | 4.28623576 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.27627467 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22961582 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.22949856 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.22101226 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.19772296 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 4.18550701 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.18550701 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.17891135 |
| 26 | Nephritis (HP:0000123) | 3.96792573 |
| 27 | Fat malabsorption (HP:0002630) | 3.91004632 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.89472678 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.76470225 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.69671253 |
| 31 | Abnormality of complement system (HP:0005339) | 3.69329145 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.57560049 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.57112896 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.51616879 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.46336622 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.29913616 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.25155178 |
| 38 | Ketoacidosis (HP:0001993) | 3.23051119 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.18198556 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.11219579 |
| 41 | Neonatal hypoglycemia (HP:0001998) | 2.94943613 |
| 42 | Myocardial infarction (HP:0001658) | 2.93346993 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.92972287 |
| 44 | Steatorrhea (HP:0002570) | 2.92915902 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.89062722 |
| 46 | Metabolic acidosis (HP:0001942) | 2.85341104 |
| 47 | Skin nodule (HP:0200036) | 2.78263159 |
| 48 | Spontaneous abortion (HP:0005268) | 2.76873303 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.73801976 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.73801976 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.73115130 |
| 52 | Osteomalacia (HP:0002749) | 2.71848897 |
| 53 | Vascular calcification (HP:0004934) | 2.69030387 |
| 54 | Lethargy (HP:0001254) | 2.68101713 |
| 55 | Fair hair (HP:0002286) | 2.67945190 |
| 56 | Gout (HP:0001997) | 2.64640682 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.64242692 |
| 58 | Reduced antithrombin III activity (HP:0001976) | 2.62260996 |
| 59 | Spastic diplegia (HP:0001264) | 2.50983153 |
| 60 | Pulmonary embolism (HP:0002204) | 2.48585591 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.44077468 |
| 62 | Glomerulonephritis (HP:0000099) | 2.43592534 |
| 63 | Cerebral edema (HP:0002181) | 2.42619046 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.39894850 |
| 65 | Purpura (HP:0000979) | 2.39884491 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.39793146 |
| 67 | Irritability (HP:0000737) | 2.38180437 |
| 68 | Mitral stenosis (HP:0001718) | 2.37122206 |
| 69 | Acanthocytosis (HP:0001927) | 2.34720794 |
| 70 | Cholelithiasis (HP:0001081) | 2.34466688 |
| 71 | Neonatal onset (HP:0003623) | 2.33883162 |
| 72 | Generalized aminoaciduria (HP:0002909) | 2.28538135 |
| 73 | Malnutrition (HP:0004395) | 2.28185791 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 2.23992410 |
| 75 | Cholecystitis (HP:0001082) | 2.23992410 |
| 76 | Pancreatitis (HP:0001733) | 2.20664401 |
| 77 | Amyloidosis (HP:0011034) | 2.19887469 |
| 78 | Late onset (HP:0003584) | 2.18866418 |
| 79 | Brushfield spots (HP:0001088) | 2.18586077 |
| 80 | Vomiting (HP:0002013) | 2.16193133 |
| 81 | Esophageal varix (HP:0002040) | 2.15977865 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.15536377 |
| 83 | Enlarged kidneys (HP:0000105) | 2.14540164 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 2.11116377 |
| 85 | Hydroxyprolinuria (HP:0003080) | 2.11116377 |
| 86 | Menorrhagia (HP:0000132) | 2.07514125 |
| 87 | Hemorrhage of the eye (HP:0011885) | 2.05856062 |
| 88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05737514 |
| 89 | Opisthotonus (HP:0002179) | 2.04127931 |
| 90 | Gingival bleeding (HP:0000225) | 2.01953219 |
| 91 | Elevated alkaline phosphatase (HP:0003155) | 2.01707036 |
| 92 | Thrombophlebitis (HP:0004418) | 1.99036621 |
| 93 | Rickets (HP:0002748) | 1.98533220 |
| 94 | Hyperphosphaturia (HP:0003109) | 1.98025073 |
| 95 | Alkalosis (HP:0001948) | 1.97184842 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.97058520 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96003016 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 1.94852725 |
| 99 | Abnormality of the gallbladder (HP:0005264) | 1.94331822 |
| 100 | Proximal tubulopathy (HP:0000114) | 1.93588955 |
| 101 | Arthropathy (HP:0003040) | 1.92162581 |
| 102 | Poikilocytosis (HP:0004447) | 1.91603846 |
| 103 | Increased serum ferritin (HP:0003281) | 1.91504656 |
| 104 | Generalized hypopigmentation of hair (HP:0011358) | 1.90192789 |
| 105 | Renal cortical cysts (HP:0000803) | 1.88595470 |
| 106 | Hypophosphatemic rickets (HP:0004912) | 1.88391826 |
| 107 | Joint swelling (HP:0001386) | 1.86818284 |
| 108 | Hyperuricemia (HP:0002149) | 1.86489792 |
| 109 | Increased purine levels (HP:0004368) | 1.86489792 |
| 110 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84863169 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84046247 |
| 112 | Hypertriglyceridemia (HP:0002155) | 1.83611989 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.82153953 |
| 114 | Status epilepticus (HP:0002133) | 1.80407876 |
| 115 | Epistaxis (HP:0000421) | 1.80326813 |
| 116 | Glycosuria (HP:0003076) | 1.79474775 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78703484 |
| 118 | Gangrene (HP:0100758) | 1.78491939 |
| 119 | Cerebral palsy (HP:0100021) | 1.75396719 |
| 120 | Abnormality of urine glucose concentration (HP:0011016) | 1.74302894 |
| 121 | Abnormality of the Achilles tendon (HP:0005109) | 1.71328928 |
| 122 | Atrioventricular block (HP:0001678) | 1.70236528 |
| 123 | Abnormality of vitamin metabolism (HP:0100508) | 1.67370129 |
| 124 | Blue irides (HP:0000635) | 1.66093352 |
| 125 | Increased mean platelet volume (HP:0011877) | 1.56544270 |
| 126 | Abnormal urine phosphate concentration (HP:0012599) | 1.56327232 |
| 127 | Abnormal delivery (HP:0001787) | 1.53283966 |
| 128 | Bile duct proliferation (HP:0001408) | 1.52074078 |
| 129 | Abnormal biliary tract physiology (HP:0012439) | 1.52074078 |
| 130 | Impaired platelet aggregation (HP:0003540) | 1.45619165 |
| 131 | Abnormal platelet function (HP:0011869) | 1.45619165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.40206497 |
| 2 | SIK1 | 4.85524802 |
| 3 | FGFR4 | 4.39517198 |
| 4 | ERN1 | 4.08041633 |
| 5 | INSRR | 3.00560136 |
| 6 | TAOK3 | 2.72146869 |
| 7 | ERBB4 | 2.40896216 |
| 8 | PKN2 | 2.33818018 |
| 9 | MST1R | 2.31275588 |
| 10 | MAP2K4 | 2.30030187 |
| 11 | TRIB3 | 2.19009395 |
| 12 | NTRK3 | 2.08888385 |
| 13 | FLT3 | 1.90985792 |
| 14 | TNK2 | 1.83180020 |
| 15 | MAPK11 | 1.73681374 |
| 16 | PIK3CG | 1.72326246 |
| 17 | PRPF4B | 1.62158937 |
| 18 | LATS1 | 1.60040728 |
| 19 | TYK2 | 1.56443861 |
| 20 | ABL2 | 1.44990813 |
| 21 | FGFR2 | 1.43097871 |
| 22 | DAPK2 | 1.39859639 |
| 23 | FRK | 1.38749074 |
| 24 | PTK6 | 1.36921616 |
| 25 | NEK9 | 1.30986111 |
| 26 | PRKG1 | 1.27747598 |
| 27 | KDR | 1.25823246 |
| 28 | CAMK1D | 1.25289651 |
| 29 | PRKAA2 | 1.25198942 |
| 30 | PINK1 | 1.24847389 |
| 31 | JAK2 | 1.18672244 |
| 32 | CAMKK2 | 1.18462866 |
| 33 | FER | 1.14734418 |
| 34 | MAP2K3 | 1.14333087 |
| 35 | NLK | 1.14080038 |
| 36 | MAP3K7 | 1.13948963 |
| 37 | ARAF | 1.07487929 |
| 38 | PRKACA | 1.07007197 |
| 39 | STK38L | 1.05710577 |
| 40 | GRK6 | 1.01928050 |
| 41 | JAK1 | 1.00594879 |
| 42 | CAMKK1 | 0.99019690 |
| 43 | MAPK4 | 0.96599399 |
| 44 | TBK1 | 0.96345221 |
| 45 | MAP3K14 | 0.93933843 |
| 46 | PRKCZ | 0.92247914 |
| 47 | BLK | 0.90391137 |
| 48 | MET | 0.89773478 |
| 49 | TIE1 | 0.89074401 |
| 50 | WNK3 | 0.87363549 |
| 51 | CDK6 | 0.85962251 |
| 52 | MAP3K3 | 0.84955158 |
| 53 | MAPK12 | 0.82229726 |
| 54 | ERBB2 | 0.82059284 |
| 55 | AKT3 | 0.81415826 |
| 56 | EPHB1 | 0.80605137 |
| 57 | MAP3K10 | 0.77847854 |
| 58 | RIPK1 | 0.77466475 |
| 59 | PRKACG | 0.76704299 |
| 60 | CSK | 0.76677761 |
| 61 | PRKCB | 0.73233445 |
| 62 | GSK3A | 0.73097523 |
| 63 | IRAK3 | 0.72741997 |
| 64 | PRKAA1 | 0.72232081 |
| 65 | SGK3 | 0.69406606 |
| 66 | MAP3K11 | 0.69014498 |
| 67 | TGFBR2 | 0.68451871 |
| 68 | PRKACB | 0.67698607 |
| 69 | RPS6KA3 | 0.67558587 |
| 70 | MAP2K6 | 0.67316983 |
| 71 | DYRK1B | 0.66808381 |
| 72 | CSNK1D | 0.66094560 |
| 73 | MAPK15 | 0.66093503 |
| 74 | CAMK1G | 0.65876614 |
| 75 | FGFR3 | 0.64661489 |
| 76 | PDK4 | 0.64215374 |
| 77 | PDK3 | 0.64215374 |
| 78 | SGK1 | 0.59653969 |
| 79 | EPHA3 | 0.59344304 |
| 80 | CAMK2G | 0.57708505 |
| 81 | PDPK1 | 0.56569261 |
| 82 | MAP2K2 | 0.54667181 |
| 83 | MAPK7 | 0.54650307 |
| 84 | SRC | 0.54102157 |
| 85 | PTK2 | 0.53474636 |
| 86 | CSF1R | 0.52757446 |
| 87 | ZAP70 | 0.51963918 |
| 88 | SGK2 | 0.50368276 |
| 89 | KIT | 0.49932808 |
| 90 | CSNK1E | 0.47755341 |
| 91 | IGF1R | 0.47089086 |
| 92 | TAOK2 | 0.46889122 |
| 93 | MAP3K6 | 0.46733523 |
| 94 | IKBKE | 0.46484923 |
| 95 | EPHA4 | 0.45907479 |
| 96 | PRKCQ | 0.45557585 |
| 97 | RET | 0.45135695 |
| 98 | MAP2K1 | 0.44128216 |
| 99 | SGK223 | 0.44108275 |
| 100 | SGK494 | 0.44108275 |
| 101 | MAP3K2 | 0.43386499 |
| 102 | CSNK1A1 | 0.42739426 |
| 103 | CSNK1G1 | 0.41541022 |
| 104 | CDK4 | 0.41202881 |
| 105 | MAP3K5 | 0.40173323 |
| 106 | STK16 | 0.39668778 |
| 107 | CSNK2A1 | 0.39506112 |
| 108 | GRK1 | 0.37868566 |
| 109 | PDK1 | 0.36818790 |
| 110 | MAPK3 | 0.36773957 |
| 111 | CSNK2A2 | 0.36327574 |
| 112 | MTOR | 0.36079993 |
| 113 | STK38 | 0.36053148 |
| 114 | IRAK2 | 0.35165745 |
| 115 | MAP3K13 | 0.33328319 |
| 116 | PRKCG | 0.33245952 |
| 117 | PRKCE | 0.32359112 |
| 118 | GRK7 | 0.32158607 |
| 119 | ICK | 0.32022744 |
| 120 | SCYL2 | 0.32008574 |
| 121 | PIK3CA | 0.29404809 |
| 122 | IRAK1 | 0.29257379 |
| 123 | CAMK4 | 0.27573858 |
| 124 | EGFR | 0.26935258 |
| 125 | LATS2 | 0.26383731 |
| 126 | PRKCA | 0.24543589 |
| 127 | PDK2 | 0.22614638 |
| 128 | MYLK | 0.21381778 |
| 129 | ABL1 | 0.20956845 |
| 130 | PDGFRA | 0.19167202 |
| 131 | PKN1 | 0.19147494 |
| 132 | MAP3K1 | 0.19103736 |
| 133 | CSNK1G2 | 0.18949891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.34613270 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53797546 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.43658648 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29690154 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97629295 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.76317942 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69077141 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66084409 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59260394 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56607154 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51630577 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50369597 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35268453 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.26436602 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.12169737 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08539761 |
| 17 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.03962672 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97518323 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89931060 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87651592 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84709496 |
| 22 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83765682 |
| 23 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82108141 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81682228 |
| 25 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.81211346 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77880534 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72034957 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71831797 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71576707 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70760592 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70249425 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59769996 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59380713 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52500658 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.51232139 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46149105 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44071697 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43298979 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34756719 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33731928 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29666276 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26710737 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.20357685 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18230328 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16647608 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16000008 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15875361 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09108992 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06416153 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06008418 |
| 51 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.03659137 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98786922 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96505835 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95934778 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92601769 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89910661 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87161463 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85984636 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.84775103 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83882668 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79440290 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71502124 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68658867 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64307271 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62443947 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62177811 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58755223 |
| 68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45771149 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31993874 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27939639 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27743669 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.26802704 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25425814 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.24339930 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22455198 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17723066 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16264782 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12218498 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08949972 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.04399363 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.04260852 |
| 82 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2796792 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2757565 |
| 84 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2592280 |
| 85 | Pertussis_Homo sapiens_hsa05133 | -0.2588562 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2552583 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2304160 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2250824 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2235458 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2118528 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2116270 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2049566 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1957117 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1950157 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1888896 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1830316 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1689720 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1666820 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1604414 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1551279 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1408970 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1195422 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1156782 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1115772 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0696674 |
| 106 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0667396 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0574310 |
| 108 | * Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0556643 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0543110 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | -0.0176209 |

